BRIEF-Charles River Q4 Adjusted EPS USD 2.39 Vs. IBES Estimate USD 2.34

Charles River Laboratories International, Inc. +1.83% Pre

Charles River Laboratories International, Inc.

CRL

155.46

155.46

+1.83%

0.00% Pre

Feb 18 (Reuters) - Charles River Q4 EPS USD -5.62.

  • Q4 revenue USD 994.2 million vs. IBES estimate USD 987 million
  • Q4 adjusted net income USD 118.8 million vs. IBES estimate USD 116.3 million
Every question you ask will be answered
Scan the QR code to contact us
whatsapp
Also you can contact us via